Back to top

Image: Bigstock

Here's What Key Metrics Tell Us About H. B. Fuller (FUL) Q1 Earnings

Read MoreHide Full Article

H. B. Fuller (FUL - Free Report) reported $788.66 million in revenue for the quarter ended February 2025, representing a year-over-year decline of 2.7%. EPS of $0.54 for the same period compares to $0.67 a year ago.

The reported revenue compares to the Zacks Consensus Estimate of $765.86 million, representing a surprise of +2.98%. The company delivered an EPS surprise of +10.20%, with the consensus EPS estimate being $0.49.

While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare to Wall Street expectations to determine their next course of action, some key metrics always provide a better insight into a company's underlying performance.

As these metrics influence top- and bottom-line performance, comparing them to the year-ago numbers and what analysts estimated helps investors project a stock's price performance more accurately.

Here is how H. B. Fuller performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:

  • Net Revenue- Engineering Adhesives: $236.76 million compared to the $334.65 million average estimate based on two analysts. The reported number represents a change of -28% year over year.
  • Net Revenue- Hygiene, Health and Consumable Adhesives: $368.23 million versus the two-analyst average estimate of $338.72 million. The reported number represents a year-over-year change of +0.1%.
  • Adjusted EBITDA- Hygiene, Health and Consumable Adhesives: $46.89 million versus the two-analyst average estimate of $47.56 million.
  • Adjusted EBITDA- Engineering Adhesives: $44.19 million compared to the $54.49 million average estimate based on two analysts.
View all Key Company Metrics for H. B. Fuller here>>>

Shares of H. B. Fuller have returned -7% over the past month versus the Zacks S&P 500 composite's -2.9% change. The stock currently has a Zacks Rank #4 (Sell), indicating that it could underperform the broader market in the near term.

See More Zacks Research for These Tickers


Normally $25 each - click below to receive one report FREE:


H. B. Fuller Company (FUL) - free report >>

Published in